Stephen Bloch
InvestorGeneral Partner / East Coast at Canaan Partners · Special Advisor at JSD Capital, LLC
Westport, Connecticut
Writes $250K – $20M checks · typically $10M
Find your path to Stephen
Sign up to see every warm intro you have to Stephen
- Paths you didn't know you had: your email and LinkedIn already hold routes to Stephen. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
Contact· self-published, not guessed
Invests in
BiotechConsumerDeep TechDigital HealthEnterprise SoftwareFintechHardwareHealthtechMedical Devices
Beyond investing
- Founded
- Stephen Bloch helped found and manage Radiology Management Sciences (RMS), OmniSonics Medical Technologies, and TeleRad.
- Boards
- Stephen Bloch is a member of Dartmouth Medical School's Board of Advisors.
- More
- Stephen Bloch is a former practicing physician.
From published sources — common ground for a warm intro.
Deals · 6
Liquidia CorporationBoard seat
via Canaan Partners · filed Apr 2021 · $21.7M raise
IantrekBoard seat
via Canaan Partners · filed Oct 2020 · $5.2M raise
Liquidia TechnologiesBoard seat
via Canaan Partners · filed Jan 2020 · $22.4M raise
Dicom GridBoard seat
via Canaan Partners · filed Nov 2017 · $7.4M raise
TruverisBoard seat
via Canaan Partners · filed Aug 2017 · $34.7M raise
Envisia TherapeuticsBoard seat
via Canaan Partners · filed Oct 2015 · $5.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Ambra HealthAmicus TherapeuticsCorviumGenome MedicalGenome MedicalLiquidiaMarinus PharmaceuticalsOnkos SurgicalOnkos Surgical
Investor
Advanced BioHealingAmbra HealthAmicus TherapeuticsCorviumGenome Medical, Inc.Marinus PharmaceuticalsOnkos SurgicalSample6
Sources: curated public sources · SEC Form D filings · the firm's website.
Colleagues at Canaan Partners
Network3
Investors connected to Stephen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Stephen Bloch?
- Stephen Bloch is a former physician and 20+ year healthcare investor across biopharma, medtech, and digital health who combines General Partner experience with running EvolveImmune Therapeutics as an active operator-investor.
- Where does Stephen Bloch work?
- Stephen Bloch is General Partner / East Coast at Canaan Partners and Special Advisor at JSD Capital, LLC.
- What does Stephen Bloch invest in?
- Stephen Bloch invests in Biotech, Consumer, Deep Tech, Digital Health, Enterprise Software, Fintech, Hardware, Healthtech, Medical Devices.
- What check size does Stephen Bloch write?
- Stephen Bloch typically writes checks of $250K – $20M.
- What boards does Stephen Bloch sit on?
- Stephen Bloch holds tracked board seats at Ambra Health, Amicus Therapeutics, Corvium, Dicom Grid, Envisia Therapeutics, Genome Medical, Genome Medical, Iantrek, Liquidia, Liquidia Corporation.
- What companies has Stephen Bloch invested in?
- Investments tracked here include Advanced BioHealing, Ambra Health, Amicus Therapeutics, Corvium, Envisia Therapeutics, Envisia Therapeutics, Genome Medical, Inc., Liquidia Corporation, Liquidia Technologies, Marinus Pharmaceuticals, Onkos Surgical, Sample6, and 1 more.
Founder mafias
Dartmouth College mafia230
Also came through, then founded or led a company.
Canaan Partners mafia12
Also came through, then founded or led a company.
EvolveImmune Therapeutics mafia3
Also came through, then founded or led a company.
Liquidia Corporation mafia3
Also came through, then founded or led a company.
Allyx Therapeutics, Inc. mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Canaan Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights

























